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From September 21–24, 2014 an eclectic and remarkable group
f 125 people gathered in Charlotte, North Carolina, USA for the First
nternational Conference on Genomics, Traits & Business, organized
y Elsevier and KeyGene. Around 40 high-ranking participants from
eading academic institutions engaged with around 80 participants
rom SME  and multinational Agro Biotech and Seed companies. In
 2.5 day program with a series of presentations and workshops
articipants investigated and discussed what is needed to initi-
te original and breakthrough innovations for genomics-based trait
nd crop improvement. Methods to foster, accelerate, and IP protect
hese new and improved traits were also addressed in the context
f how to bring them to market in an entrepreneurial way with suf-
cient ﬁnancial investments. In other words: how can we leverage
he promises of Agro Genomics and translate Genomics R&D into
ew agricultural products and novel crops for the future?
First,  it was concluded that various forms of collaborations
lmost always play an essential role. It was recognized that
uccessful Public Private Partnerships can be developed when
P and ownership issues are addressed efﬁciently while sufﬁ-
iently awarding creative and original R&D work from knowledge
roviders. But also collaborations between companies or between
ompanies and granting agencies or governmental organizations
an result in innovations with high socio-economic impact.
Second,  it was clear that in addition to an array of tradi-
ional crops with new and improved traits that will soon reach
he seed and agricultural market, a completely new set of crops
re being developed to address the needs of a bio-based econ-
my. Besides new and attractive ‘conventional’ GM Biotech traits
ther traits developed through biotechnological approaches such
s genome editing, molecular breeding, genomic selection and
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.molecular  mutagenesis will race to the market. The speed at which
these traits are introduced is contingent on the resolution of uncer-
tainties in IPR and the regulatory landscape.
Third, ‘traditional’ Agro Biotech will be complemented and
supported by new advances in biologicals, decision support con-
sultancy, climate predictions, automated greenhouse screening and
ﬁeld phenotyping.
Fourth, all of these new technologies come with a lot of data:
Big Data. Participants concluded that storing, handling, analyzing
and learning from Big Data will be extremely important to enable
the translation of R&D innovations into new products. Participants
discussed the need for High Performance computing infrastructure
and novel approaches for integrating data from the expand-
ing range of disciplines being incorporated into Agro Biotech
research.
In conclusion, we  were pleasantly surprised and encouraged by
the developments we see in various aspects of the Plant Sciences
and Biotechnology and the novel applications thereof. As we move
ahead and develop new traits and crop varieties in a manner that
values the interplay between R&D, the IP & Regulatory climate,
socio-economic impact and the role of Public/Private partnerships,
Plant Sciences and Biotechnology will continue to make a tremen-
dous contribution to feeding the growing world in 2050. Therefore
further developments and progress will be discussed in the follow-
ing meeting ‘Genomics in Business’ to be held in Amsterdam from
April 19–21, 2015.
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